Amplifon

Profile narrative

Amplifon is a global provider of hearing care products and services headquartered in Milan, Italy. The company specializes in the retail distribution, fitting, and ongoing servicing of hearing aids and related assistive listening devices. Its core business model combines clinical audiology services with a retail footprint, offering hearing assessments, device selection, customization, and long-term aftercare including maintenance, repairs, and battery supply. Amplifon operates through a network of directly owned and franchised clinics as well as shop-in-shop locations, serving customers across Europe, the Americas, and the Asia-Pacific region. The organization positions itself at the intersection of healthcare delivery and specialized retail, addressing age-related and noise-induced hearing loss through professional audiological support.

Founded in 1950 by Algernon Charles Holland, Amplifon has grown into one of the world's largest dedicated hearing care retailers. The company is listed on the Milan Stock Exchange (Euronext Milan) under the ticker AMP and is a component of the FTSE MIB index. Its operational scale encompasses thousands of points of sale across more than twenty countries, with significant market presence in Italy, France, Germany, the United Kingdom, Spain, the United States, Canada, Australia, and New Zealand. The group employs a workforce of audiologists, hearing aid specialists, and support staff who deliver services through both proprietary brands and partnerships with medical institutions. Amplifon's revenue model derives primarily from the sale of hearing devices, which are often reimbursed in part by national health systems or private insurers depending on local regulatory frameworks.

The organization's distinguishing attributes include its vertically integrated approach to hearing care, controlling the customer journey from initial screening through device fitting and lifetime service. Amplifon has invested in proprietary digital platforms for appointment scheduling, remote device programming, and tele-audiology capabilities, reflecting a shift toward hybrid care delivery accelerated by the COVID-19 pandemic. The company also operates a private-label hearing aid portfolio alongside devices from major manufacturers such as Sonova, Demant, GN Store Nord, and WS Audiology. In February 2026, Amplifon experienced a data breach that compromised patient medical records, financial information, and Social Security numbers, with detection occurring in February and public disclosure following in November. The incident highlighted the data protection obligations inherent in its role as a healthcare service provider handling sensitive personal information across multiple jurisdictions.

Incidents

1 incident linked to this organisation.